Weight-loss Drug Saxenda Effective for Obese Children: Key Findings

Weight-loss Drug Saxenda Shows Effectiveness for Young Patients

A recent study has revealed that the weight-loss drug Saxenda is not only safe but also effective for treating obesity in children as young as 6 years old. This groundbreaking research adds to the understanding of obesity management among very young patients.

Key Findings from the Study

• Saxenda, containing liraglutide, helps reduce body mass and improve health markers in children.
• The study involved 82 children aged 6 to 11, most of whom had obesity-related health issues.
• Children who took the drug for over a year decreased their BMI by 5.8% compared to a BMI increase in the placebo group.
• Nearly 90% of participants experienced mild to moderate side effects, primarily gastrointestinal.

As obesity rates in U.S. children exceed 20%, this medication could potentially offer a viable solution where only diet and exercise were the previous options. Experts caution that any medical treatment for this age group should be carefully considered due to side effects.

Dr. Claudia Fox, a pediatric obesity expert, mentioned that access to such medication could be transformative for young patients. However, parents and healthcare providers need to weigh the risks and benefits carefully.